Vertex Pharmaceuticals Inc / Ma

JACOBS LEVY EQUITY MANAGEMENT, INC VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

17,416

Value ($000)

7,896

Weight

0.0%

2014 Q1 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	7,896	0.0%	17,416	12/31/2025
2025 Q2	8/14/2025	22,686	0.1%	50,956	6/30/2025
2025 Q1	5/15/2025	32,112	0.1%	66,234	3/31/2025
2023 Q4	2/14/2024	41,042	0.2%	100,868	12/31/2023
2023 Q3	11/17/2023	198,031	1.2%	569,480	9/30/2023
2023 Q2	8/14/2023	193,716	1.1%	550,470	6/30/2023
2023 Q1	5/15/2023	196,104	1.2%	622,414	3/31/2023
2022 Q4	2/14/2023	183,662	1.2%	635,992	12/31/2022
2022 Q3	11/15/2022	58,393	0.5%	201,674	9/30/2022
2022 Q2	8/15/2022	39,299	0.3%	139,461	6/30/2022
2022 Q1	5/16/2022	13,840	0.1%	53,033	3/31/2022
2021 Q4	2/14/2022	7,744	0.1%	35,264	12/31/2021
2021 Q3	11/15/2021	82,917	0.6%	457,122	9/30/2021
2021 Q2	8/16/2021	127,009	0.9%	629,909	6/30/2021
2021 Q1	5/17/2021	3,800	0.0%	17,684	3/31/2021
2020 Q4	2/16/2021	31,284	0.3%	132,369	12/31/2020
2020 Q3	11/16/2020	9,774	0.1%	35,918	9/30/2020
2020 Q2	8/17/2020	15,788	0.2%	54,383	6/30/2020
2014 Q1	5/15/2014	4,874	0.1%	68,920	3/31/2014